SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002631
Filing Date
2019-04-26
Accepted
2019-04-26 15:42:58
Documents
6
Period of Report
2019-06-11
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238601zdef14a.htm DEF 14A 370149
2 G631132.JPG g631132.jpg GRAPHIC 16926
3 G752160.JPG g752160.jpg GRAPHIC 3442
4 G249170.JPG g249170.jpg GRAPHIC 4912
5 G26532BGI001.GIF g26532bgi001.gif GRAPHIC 103694
6 G26532BGI002.GIF g26532bgi002.gif GRAPHIC 102740
  Complete submission text file 0001047469-19-002631.txt   690864
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37926 | Film No.: 19771540
SIC: 2834 Pharmaceutical Preparations